Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

GSK Insider Trading (GlaxoSmithKline)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £109,609.91
Insider Selling (Last 12 Months): £547,899.10

GlaxoSmithKline Insider Trading History Chart

This chart shows the insider buying and selling history at GlaxoSmithKline by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GlaxoSmithKline Share Price & Price History

Current Price: GBX 1,798.40
Price Change: Price Increase of +43 (2.45%)
As of 05/16/2022 05:36 PM ET

This chart shows the closing price history over time for GSK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity

GlaxoSmithKline Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/23/2022Charles BancroftInsiderBuy2,790GBX 2,114£58,980.60
2/14/2022Emma WalmsleyInsiderSell34,031GBX 1,610£547,899.10
2/9/2022Emma WalmsleyInsiderBuy8GBX 1,627£130.16
1/12/2022Emma WalmsleyInsiderBuy7GBX 1,638£114.66
11/22/2021Hal BarronInsiderBuy2,422GBX 2,065£50,014.30
10/11/2021Emma WalmsleyInsiderBuy9GBX 1,397£125.73
8/10/2021Emma WalmsleyInsiderBuy8GBX 1,447£115.76
7/9/2021Emma WalmsleyInsiderBuy9GBX 1,430£128.70
5/12/2021Emma WalmsleyInsiderBuy10GBX 1,341£134.10
4/28/2021Urs RohnerInsiderBuy629GBX 1,340£8,428.60
4/13/2021Emma WalmsleyInsiderBuy9GBX 1,291£116.19
3/1/2021Emma WalmsleyInsiderSell32,346GBX 1,211£391,710.06
2/9/2021Emma WalmsleyInsiderBuy10GBX 1,272£127.20
2/3/2021Urs RohnerInsiderBuy619GBX 1,361£8,424.59
1/12/2021Emma WalmsleyInsiderBuy9GBX 1,384£124.56
12/30/2020Manvinder Singh BangaInsiderBuy36,600GBX 1,376£503,616
12/9/2020Emma WalmsleyInsiderBuy9GBX 1,403£126.27
11/10/2020Emma WalmsleyInsiderBuy9GBX 1,462£131.58
10/28/2020Jonathan SymondsInsiderBuy3,240,741GBX 1,350£43,750,003.50
10/9/2020Emma WalmsleyInsiderBuy8GBX 1,440£115.20
9/10/2020Emma WalmsleyInsiderBuy8GBX 1,520£121.60
8/11/2020Emma WalmsleyInsiderBuy8GBX 1,598£127.84
7/9/2020Emma WalmsleyInsiderBuy8GBX 1,610£128.80
5/12/2020Emma WalmsleyInsiderBuy7GBX 1,693£118.51
4/9/2020Emma WalmsleyInsiderBuy28GBX 1,536£430.08
3/10/2020Emma WalmsleyInsiderBuy8GBX 1,569£125.52
2/17/2020Emma WalmsleyInsiderSell11,680GBX 1,661£194,004.80
2/11/2020Emma WalmsleyInsiderBuy7GBX 1,726£120.82
2/5/2020Judy LewentInsiderBuy788GBX 2,344£18,470.72
1/10/2020Emma WalmsleyInsiderBuy7GBX 1,800£126
12/10/2019Emma WalmsleyInsiderBuy8GBX 1,731£138.48
11/11/2019Emma WalmsleyInsiderBuy7GBX 1,727£120.89
10/30/2019Vivienne CoxInsiderBuy308GBX 1,725£5,313
10/9/2019Emma WalmsleyInsiderBuy7GBX 1,729£121.03
9/10/2019Emma WalmsleyInsiderBuy8GBX 1,658£132.64
8/9/2019Emma WalmsleyInsiderBuy7GBX 1,674£117.18
7/24/2019Vivienne CoxInsiderBuy434GBX 1,654£7,178.36
7/9/2019Emma WalmsleyInsiderBuy8GBX 1,636£130.88
6/11/2019Emma WalmsleyInsiderBuy7GBX 1,585£110.95
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for GlaxoSmithKline (LON:GSK)

GlaxoSmithKline logo
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Read More on GlaxoSmithKline

Today's Range

Now: GBX 1,798.40
Low: 1,747
High: 1,798.40

50 Day Range

MA: GBX 1,695.99
Low: 1,508.60
High: 1,810.40

52 Week Range

Now: GBX 1,798.40
Low: 1,328.20
High: 1,817


7,981,232 shs

Average Volume

8,831,466 shs

Market Capitalization

£90.46 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of GlaxoSmithKline?

GlaxoSmithKline's top insider shareholders include:
  1. Charles Bancroft (Insider)
  2. Emma Walmsley (Insider)
  3. Hal Barron (Insider)
  4. Jonathan Symonds (Insider)
  5. Manvinder Singh Banga (Insider)
  6. Urs Rohner (Insider)
Learn More about top insider investors at GlaxoSmithKline.
Is the US Military Secretly Under Chinese Control?
Alarmingly, the answer may be "yes". Communist China now controls 80% of the lithium that powers most US military vehicles and equipment. The threat level is so high that the White House recently declared a state of emergency on lithium...
Discover How To Invest in Lithium Mining